MedTrace Logo

The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD

NCT06776159 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-09-11

No results posted yet for this study

Summary

Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.

Conditions

  • CVD - Cardiovascular Disease
  • Bruise
  • Pain

Interventions

OTHER

Active Control

Patients in the control group will receive the usual practice of subcutaneous LMWH injection administered by nurses.

OTHER

Standardized injection protocol

Nurses administer LMWH according to the standardized evidence-based protocol.

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Arkers Wong · The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-24
Primary Completion
2025-12-31
Completion
2026-01-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06776159 on ClinicalTrials.gov